Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran)

Clinical trial NCT06613984 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06613984
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

COVID-19 Vaccination

Start date: 2024-10-11
Primary completion: 2026-12-30
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.